1.80
0.16 (9.76%)
Penutupan Terdahulu | 1.64 |
Buka | 1.66 |
Jumlah Dagangan | 3,050,521 |
Purata Dagangan (3B) | 1,778,868 |
Modal Pasaran | 19,800,000 |
Harga / Pendapatan (P/E TTM) | 10.59 |
Harga / Jualan (P/S) | 0.520 |
Harga / Buku (P/B) | 2.03 |
Julat 52 Minggu |
Margin Keuntungan | 9.19% |
Margin Operasi (TTM) | 9.24% |
EPS Cair (TTM) | 0.170 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 58.20% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 232.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 43.88% |
Nisbah Semasa (MRQ) | 2.46 |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Pharmaceutical Retailers (US) | Bercampur | Bercampur |
Pharmaceutical Retailers (Global) | Menurun | Bercampur | |
Stok | Hong Kong Pharma Digital Techno | - | - |
AISkor Stockmoo
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 2.0 |
Purata | 0.00 |
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market. |
|
Sektor | Healthcare |
Industri | Pharmaceutical Retailers |
% Dimiliki oleh Orang Dalam | 68.01% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
28 Mar 2025 | Pengumuman | Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |